BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26974375)

  • 1. Chroman-4-one and chromone based somatostatin β-turn mimetics.
    Fridén-Saxin M; Seifert T; Malo M; da Silva Andersson K; Pemberton N; Dyrager C; Friberg A; Dahlén K; Wallén EA; Grøtli M; Luthman K
    Eur J Med Chem; 2016 May; 114():59-64. PubMed ID: 26974375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of somatostatin mimetics based on 1-deoxynojirimycin.
    Chagnault V; Lalot J; Murphy PV
    ChemMedChem; 2008 Jul; 3(7):1071-6. PubMed ID: 18418832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A light-activated beta-turn scaffold within a somatostatin analog: NMR structure and biological activity.
    Ulysse LG; Chmielewski J
    Chem Biol Drug Des; 2006 Feb; 67(2):127-36. PubMed ID: 16492160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin sst4 ligands: chemistry and pharmacology.
    Crider AM; Witt KA
    Mini Rev Med Chem; 2007 Mar; 7(3):213-20. PubMed ID: 17346214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol: A minimal scaffold for non-peptide peptidomimetics of the i + 1 and i + 2 positions of the beta-turn of somatostatin.
    Mowery BP; Prasad V; Kenesky CS; Angeles AR; Taylor LL; Feng JJ; Chen WL; Lin A; Cheng FC; Smith AB; Hirschmann R
    Org Lett; 2006 Sep; 8(20):4397-400. PubMed ID: 16986909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide somatostatin agonists with sst4 selectivity: synthesis and structure-activity relationships of thioureas.
    Liu S; Tang C; Ho B; Ankersen M; Stidsen CE; Crider AM
    J Med Chem; 1998 Nov; 41(24):4693-705. PubMed ID: 9822540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly potent 4-amino-indolo[2,3-c]azepin-3-one-containing somatostatin mimetics with a range of sst receptor selectivities.
    Feytens D; De Vlaeminck M; Cescato R; Tourwé D; Reubi JC
    J Med Chem; 2009 Jan; 52(1):95-104. PubMed ID: 19067538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.
    Grace CR; Erchegyi J; Koerber SC; Reubi JC; Rivier J; Riek R
    J Med Chem; 2006 Jul; 49(15):4487-96. PubMed ID: 16854054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.
    Fridén-Saxin M; Seifert T; Landergren MR; Suuronen T; Lahtela-Kakkonen M; Jarho EM; Luthman K
    J Med Chem; 2012 Aug; 55(16):7104-13. PubMed ID: 22746324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugate addition of isocyanides to chromone 3-carboxylic acid: an efficient one-pot synthesis of chroman-4-one 2-carboxamides.
    Neo AG; Díaz J; Marcaccini S; Marcos CF
    Org Biomol Chem; 2012 May; 10(17):3406-16. PubMed ID: 22434156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of somatostatin mimetics based on the 1-deoxymannojirimycin scaffold.
    Gouin SG; Murphy PV
    J Org Chem; 2005 Oct; 70(21):8527-32. PubMed ID: 16209603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.
    Roy SK; Kumari N; Gupta S; Pahwa S; Nandanwar H; Jachak SM
    Eur J Med Chem; 2013 Aug; 66():499-507. PubMed ID: 23832254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
    Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
    J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and binding affinities of pyrrolinone-based somatostatin mimetics.
    Smith AB; Charnley AK; Mesaros EF; Kikuchi O; Wang W; Benowitz A; Chu CL; Feng JJ; Chen KH; Lin A; Cheng FC; Taylor L; Hirschmann R
    Org Lett; 2005 Feb; 7(3):399-402. PubMed ID: 15673249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-pyridylthioureas: novel nonpeptide somatostatin agonists with SST4 selectivity.
    Liu S; Crider AM; Tang C; Ho B; Ankersen M; Stidsen CE
    Curr Pharm Des; 1999 Apr; 5(4):255-63. PubMed ID: 10101224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel A3 adenosine receptor ligands based on chromone scaffold.
    Gaspar A; Reis J; Kachler S; Paoletta S; Uriarte E; Klotz KN; Moro S; Borges F
    Biochem Pharmacol; 2012 Jul; 84(1):21-9. PubMed ID: 22433284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic hexapeptide analogs of somatostatin containing bridge modifications. Syntheses and conformational analyses.
    Huang Z; Pröbstl A; Spencer JR; Yamazaki T; Goodman M
    Int J Pept Protein Res; 1993 Oct; 42(4):352-65. PubMed ID: 7902342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a benzomacrolactone-based somatostatin mimetic.
    Zhou J; Matos MC; Murphy PV
    Org Lett; 2011 Nov; 13(21):5716-9. PubMed ID: 21988463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.